Patents by Inventor Wha Bin Im

Wha Bin Im has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for glaucoma treatment
    Patent number: 7872045
    Abstract: A method is disclosed herein comprising administering a compound and a second drug to an eye of a mammal for the treatment of glaucoma or the reduction of intraocular pressure, said compound represented by the general formula I; wherein A, B, D, X, Y, Z, R1, R3 and R4 are as defined in the specification.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: January 18, 2011
    Assignee: Allergan, Inc.
    Inventors: Robert M. Burk, Mark Holoboski, Scott M. Whitcup, Wha-Bin Im
  • Treatment of inflammatory bowel disease
    Patent number: 7855226
    Abstract: Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: December 21, 2010
    Assignee: Allergan, Inc.
    Inventors: Yariv Donde, Jeremiah H. Nguyen, Karen M. Kedzie, Daniel W. Gil, John E. Donello, Wha-Bin Im
  • THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
    Publication number: 20100280250
    Abstract: A compound comprising a prodrug of a prostaglandin EP4 agonist, wherein said prodrug is an ester, ether, or amide of an amino acid is disclosed herein. Maintenance of the colonic mucosal barrier by method comprising administering a therapeutically effective amount of a prostaglandin EP4 agonist to a colon of a mammal is also disclosed herein. Dosage forms, medicaments, and compositions, related thereto are also disclosed.
    Type: Application
    Filed: July 12, 2010
    Publication date: November 4, 2010
    Inventors: Wha-Bin Im, Robert M. Burk, Mark Holoboski
  • THERAPEUTIC SUBSTITUTED LACTAMS
    Publication number: 20100168189
    Abstract: Therapeutic compounds, compositions, methods, and medicaments related thereto are disclosed herein.
    Type: Application
    Filed: February 8, 2008
    Publication date: July 1, 2010
    Inventors: David W. Old, Wha Bin Im, Vinh X. Ngo
  • SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
    Publication number: 20100093729
    Abstract: A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Application
    Filed: January 29, 2008
    Publication date: April 15, 2010
    Applicant: Allergan, Inc.
    Inventors: David W. Old, Wha-Bin Im
  • METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS
    Publication number: 20100081631
    Abstract: Methods are provided directed to administering a therapeutically effective amount of a prostaglandin EP4 agonist component to a mammal afflicted with or prone to affliction with a disease or condition selected from an esophageal ulcer, alcohol gastropathy, a duodenal ulcer, a gastric ulcer, non-steroidal anti-inflammatory drug-induced gastroenteropathy and intestinal ischemia. Such administration results in treating or preventing the disease or condition.
    Type: Application
    Filed: December 11, 2007
    Publication date: April 1, 2010
    Inventors: Guang Liang Jiang, Wha Bin Im, Larry A. Wheeler
  • Prostaglandin prodrugs
    Patent number: 7507817
    Abstract: Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: March 24, 2009
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Vinh X. Ngo, Wha-Bin Im
  • Prostaglandin Prodrugs
    Publication number: 20080167311
    Abstract: Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein.
    Type: Application
    Filed: November 13, 2007
    Publication date: July 10, 2008
    Inventors: David W. Old, Vinh X. Ngo, Wha-Bin Im
  • Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
    Publication number: 20080132543
    Abstract: A compound comprising a prodrug of a prostaglandin EP4 agonist, wherein said prodrug is an ester, ether, or amide of a carbohydrate; or said prodrug is an ester, ether, or amide of an amino acid is disclosed herein. Maintenance of the colonic mucosal barrier by method comprising administering a therapeutically effective amount of a prostaglandin EP4 agonist to a colon of a mammal is also disclosed herein. Dosage forms, medicaments, and compositions, related thereto are also disclosed.
    Type: Application
    Filed: October 24, 2005
    Publication date: June 5, 2008
    Inventors: Wha Bin Im, Yariv Donde, Mark Holoboski, David W. Old, Karen M. Kedzie, Daniel W. Gil, John E. Donello, Robert M. Burk, Todd Gac
  • Treatment of inflammatory bowel disease
    Patent number: 7326716
    Abstract: The present invention provides a method of treating inflammatory bowel disease which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a piperidinyl prostaglandin E analog.
    Type: Grant
    Filed: November 29, 2004
    Date of Patent: February 5, 2008
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh, Karen M. Kedzie, Daniel W. Gil, Wha Bin Im
  • THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS
    Publication number: 20070232660
    Abstract: A compound comprising a prodrug of a prostaglandin EP4 agonist, wherein said prodrug is an ester, ether, or amide of an amino acid is disclosed herein. Maintenance of the colonic mucosal barrier by method comprising administering a therapeutically effective amount of a prostaglandin EP4 agonist to a colon of a mammal is also disclosed herein. Dosage forms, medicaments, and compositions, related thereto are also disclosed.
    Type: Application
    Filed: March 19, 2007
    Publication date: October 4, 2007
    Inventors: Wha-Bin Im, Robert M. Burk, Mark Holoboski
  • THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS
    Publication number: 20070123569
    Abstract: Methods are provided directed to adminstering a therapeutically effective amount of a prostaglandin EP4 agonist component to a mammal afflicted with or prone to affliction with a disease or condition selected from an esophageal ulcer, alcohol gastrophathy, a duodenal ulcer, non-steroidal anti-inflammatory drug-induced gastropathy, non-steroidal anti-inflammatory drug-induced enteropathy and intestinal ischemia. Such administration results in treating or preventing the disease or condition.
    Type: Application
    Filed: November 28, 2006
    Publication date: May 31, 2007
    Applicant: ALLERGAN, INC.
    Inventors: Guang-Liang Jiang, Wha Bin Im, Larry Wheeler
  • Therapeutic methods using prostaglandin EP4 agonist components
    Publication number: 20070123568
    Abstract: Methods are provides directed to administering a therapeutically effective amount of a prostaglandin EP4 agonist component to a mammal afflicted with or prone to affliction with a disease or condition selected from an esophageal ulcer, alcohol gastropathy, a duodenal ulcer, non-steroidal anti-inflammatory drug-induced gastroentroeropathy and intestinal ischemia. Such administration results in treating or preventing the disease or condition.
    Type: Application
    Filed: November 30, 2005
    Publication date: May 31, 2007
    Applicant: Allergan, Inc.
    Inventors: Guang-Liang Jiang, Wha Bin Im, Larry Wheeler
  • Combination therapy for glaucoma treatment
    Publication number: 20050209194
    Abstract: A method is disclosed herein comprising administering a compound and a second drug to an eye of a mammal for the treatment of glaucoma or the reduction of intraocular pressure, said compound represented by the general formula I; wherein A, B, D, X, Y, Z, R1, R3 and R4 are as defined in the specification.
    Type: Application
    Filed: May 16, 2005
    Publication date: September 22, 2005
    Inventors: Robert Burk, Mark Holoboski, Scott Whitcup, Wha-Bin Im
  • Treatment of inflammatory bowel disease
    Publication number: 20050164992
    Abstract: Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I wherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.
    Type: Application
    Filed: March 17, 2005
    Publication date: July 28, 2005
    Applicant: ALLERGAN, INC.
    Inventors: Yariv Donde, Jeremiah Nguyen, Karen Kedzie, Daniel Gil, John Donello, Wha-Bin Im